Literature DB >> 19726563

The transforming growth factor-beta type III receptor mediates distinct subcellular trafficking and downstream signaling of activin-like kinase (ALK)3 and ALK6 receptors.

Nam Y Lee1, Kellye C Kirkbride, Richard D Sheu, Gerard C Blobe.   

Abstract

Bone morphogenetic proteins (BMPs) signal through the BMP type I and type II receptors to regulate cellular processes, including embryonic development. The type I BMP receptors activin-like kinase (ALK)3 and ALK6 share a high degree of homology, yet possess distinct signaling roles. Here, we report that although the transforming growth factor (TGF)-beta type III receptor (TbetaRIII) enhanced both ALK3 and ALK6 signaling, TbetaRIII more potently enhanced ALK6-mediated stimulation of the BMP-responsive promoters XVent2 and 3GC2, and up-regulation of the early response gene Smad6. In contrast, TbetaRIII specifically enhanced ALK3-mediated up-regulation of the early response gene ID-1. TbetaRIII associated with ALK3 primarily through their extracellular domains, whereas its interaction with ALK6 required both the extracellular and cytoplasmic domains. TbetaRIII, along with its interacting scaffolding protein beta-arrestin2, induced the internalization of ALK6. In contrast, TbetaRIII colocalized with and resulted in the cell surface retention of ALK3, independently of beta-arrestin2. Although complex formation between TbetaRIII, ALK6, and beta-arrestin2 and TbetaRIII/ALK6 internalization resulted in maximal BMP signaling, the TbetaRIII mutant unable to interact with beta-arrestin2, TbetaRIII-T841A, was unable to do so. These studies support a novel role for TbetaRIII in mediating differential ALK3 and ALK6 subcellular trafficking resulting in distinct signaling downstream of ALK3 and ALK6.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726563      PMCID: PMC2762132          DOI: 10.1091/mbc.e09-07-0539

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  49 in total

Review 1.  TGFbeta signaling in growth control, cancer, and heritable disorders.

Authors:  J Massagué; S W Blain; R S Lo
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

Review 2.  Consequences of knocking out BMP signaling in the mouse.

Authors:  Guang-Quan Zhao
Journal:  Genesis       Date:  2003-01       Impact factor: 2.487

3.  Extracellular domain of TGFbeta type III receptor inhibits angiogenesis and tumor growth in human cancer cells.

Authors:  Abhik Bandyopadhyay; Yong Zhu; Shazli N Malik; Jeffrey Kreisberg; Michael G Brattain; Eugene A Sprague; Jian Luo; Fernando López-Casillas; L-Z Sun
Journal:  Oncogene       Date:  2002-05-16       Impact factor: 9.867

4.  Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors.

Authors:  L Gilboa; A Nohe; T Geissendörfer; W Sebald; Y I Henis; P Knaus
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

5.  A novel mechanism for regulating transforming growth factor beta (TGF-beta) signaling. Functional modulation of type III TGF-beta receptor expression through interaction with the PDZ domain protein, GIPC.

Authors:  G C Blobe; X Liu; S J Fang; T How; H F Lodish
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

6.  Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3.

Authors:  Vinciane Gaussin; Tom Van de Putte; Yuji Mishina; Mark C Hanks; An Zwijsen; Danny Huylebroeck; Richard R Behringer; Michael D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 7.  The endocytic pathway: a mosaic of domains.

Authors:  J Gruenberg
Journal:  Nat Rev Mol Cell Biol       Date:  2001-10       Impact factor: 94.444

8.  Signalling via type IA and type IB bone morphogenetic protein receptors (BMPR) regulates intramembranous bone formation, chondrogenesis and feather formation in the chicken embryo.

Authors:  Amir M Ashique; Katherine Fu; Joy M Richman
Journal:  Int J Dev Biol       Date:  2002-03       Impact factor: 2.203

9.  Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.

Authors:  Abhik Bandyopadhyay; Fernando López-Casillas; Shazli N Malik; José Luis Montiel; Valentín Mendoza; Junhua Yang; L-Z Sun
Journal:  Cancer Res       Date:  2002-08-15       Impact factor: 12.701

10.  The type III TGF-beta receptor regulates epithelial and cancer cell migration through beta-arrestin2-mediated activation of Cdc42.

Authors:  Karthikeyan Mythreye; Gerard C Blobe
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-01       Impact factor: 11.205

View more
  22 in total

1.  Anti-Müllerian Hormone Signaling Regulates Epithelial Plasticity and Chemoresistance in Lung Cancer.

Authors:  Tim N Beck; Vladislav A Korobeynikov; Alexander E Kudinov; Rachel Georgopoulos; Nehal R Solanki; Magda Andrews-Hoke; Timothy M Kistner; David Pépin; Patricia K Donahoe; Emmanuelle Nicolas; Margret B Einarson; Yan Zhou; Yanis Boumber; David A Proia; Ilya G Serebriiskii; Erica A Golemis
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

Review 2.  BMP signaling in vascular development and disease.

Authors:  Jonathan W Lowery; Mark P de Caestecker
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-31       Impact factor: 7.638

3.  miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

Authors:  Duo Li; Ke Liu; Zhiyong Li; Jian Wang; Xiaofeng Wang
Journal:  Cell Adh Migr       Date:  2017-11-13       Impact factor: 3.405

4.  Endocardial cell epithelial-mesenchymal transformation requires Type III TGFβ receptor interaction with GIPC.

Authors:  Todd A Townsend; Jamille Y Robinson; Tam How; Daniel M DeLaughter; Gerard C Blobe; Joey V Barnett
Journal:  Cell Signal       Date:  2011-09-14       Impact factor: 4.315

Review 5.  Signaling Receptors for TGF-β Family Members.

Authors:  Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-08-01       Impact factor: 10.005

6.  The cytoplasmic domain of TGFβR3 through its interaction with the scaffolding protein, GIPC, directs epicardial cell behavior.

Authors:  Nora S Sánchez; Cynthia R Hill; Joseph D Love; Jonathan H Soslow; Evisabel Craig; Anita F Austin; Christopher B Brown; Andras Czirok; Todd D Camenisch; Joey V Barnett
Journal:  Dev Biol       Date:  2011-08-18       Impact factor: 3.582

7.  Common pathways regulate Type III TGFβ receptor-dependent cell invasion in epicardial and endocardial cells.

Authors:  Cynthia R Clark; Jamille Y Robinson; Nora S Sanchez; Todd A Townsend; Julian A Arrieta; W David Merryman; David Z Trykall; Harold E Olivey; Charles C Hong; Joey V Barnett
Journal:  Cell Signal       Date:  2016-03-10       Impact factor: 4.315

8.  FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension.

Authors:  Edda Spiekerkoetter; Xuefei Tian; Jie Cai; Rachel K Hopper; Deepti Sudheendra; Caiyun G Li; Nesrine El-Bizri; Hirofumi Sawada; Roxanna Haghighat; Roshelle Chan; Leila Haghighat; Vinicio de Jesus Perez; Lingli Wang; Sushma Reddy; Mingming Zhao; Daniel Bernstein; David E Solow-Cordero; Philip A Beachy; Thomas J Wandless; Peter Ten Dijke; Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2013-07-15       Impact factor: 14.808

Review 9.  Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways.

Authors:  Jeffrey J Kovacs; Makoto R Hara; Chandra L Davenport; Jihee Kim; Robert J Lefkowitz
Journal:  Dev Cell       Date:  2009-10       Impact factor: 12.270

Review 10.  β-Arrestins in the immune system.

Authors:  Dianhua Jiang; Ting Xie; Jiurong Liang; Paul W Noble
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.